Previous close | 4.7500 |
Open | 2.6200 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 175.00 |
Expiry date | 2024-07-19 |
Day's range | 2.2000 - 4.7500 |
Contract range | N/A |
Volume | |
Open interest | 1.78k |
An FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to target the WHO-recommended JN.1 variant or the KP.2 variant which is the currently dominating strain in the country.
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Moderna, Inc. (NASDAQ:MRNA) is the top gene therapy stock to invest in now. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]